Rich Stuart 4
4 · TENAX THERAPEUTICS, INC. · Filed Dec 6, 2021
Insider Transaction Report
Form 4
Rich Stuart
DirectorChief Medical Officer
Transactions
- Gift
Common stock
2021-10-12+1,909,585→ 1,909,585 total(indirect: By Spouse) - Gift
Common Stock
2021-11-29+1,909,585→ 1,909,585 total(indirect: By Trust) - Gift
Common stock
2021-11-29−1,909,585→ 0 total(indirect: By Spouse) - Gift
Common Stock
2021-10-12−1,909,585→ 2,333,932 total
Holdings
- 250,000
Stock Option (right to buy)
Exercise: $1.78Exp: 2031-01-15→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Represents a gift of Issuer's common stock to the Andrea Rich 2021 Irrevocable Trust, a Spousal Lifetime Access Trust (the "Trust"), for the benefit of the Reporting Person and the Reporting Person's children.
- [F2]The Reporting Person is co-trustee of the Trust and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F3]The option becomes exercisable in four equal installments, with 25% vesting after the start of a Phase 3 clinical trial, 25% vesting after the database lock with respect to the trial, 25% vesting after the opening of an Investigational New Drug Application with the U.S. Food and Drug Administration ("FDA"), and 25% vesting after the approval from the FDA.